Home - Hexagon
Hexagon Bio is a biopharmaceutical company developing novel antibody-drug conjugate (ADC) payloads for oncology. Its proprietary natural products platform mines cytotoxic small molecules from microbial genomes using data science, genomics, synthetic biology, and automation to identify next-generation ADC payloads that overcome resistance to existing therapies and expand indication space.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2023
Sep 2021
Sep 2020
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
